Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THEBES: Tibolone Endometrial Safety Trial
NCT00745108Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Oct 2001
- Primary completion
- Jul 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 3 trial of tibolone in menopause, postmenopausal osteoporosis, sponsored by Organon & Co.. Started Oct 2001; status: completed.
02
Drugs
tibolone
03
Conditions
menopausepostmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00745108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00745108.